Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Source filing unavailable
Q4 2015 · —
Revenue$5.19B$5.19B−3.1% vs Q4 2014 Net Income$767.00M$767.00M−15.2% vs Q4 2014 EPS Diluted$0.51$0.51−13.6% vs Q4 2014 Gross Profit$2,839,000,000−0.6% Operating Incomederived$815,000,000−1.7% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$828,000,000−33.1% Free Cash Flowderived$580,000,000−39.0% Margins · derivedGross margin54.7%+1.4 pt vs Q4 2014
Operating margin15.7%+0.2 pt vs Q4 2014
Net margin14.8%−2.1 pt vs Q4 2014